ACHV
Price
$2.42
Change
-$0.13 (-5.10%)
Updated
Apr 3 closing price
Capitalization
83.94M
34 days until earnings call
AXSM
Price
$107.89
Change
-$1.86 (-1.69%)
Updated
Apr 3 closing price
Capitalization
5.26B
38 days until earnings call
Ad is loading...

ACHV vs AXSM

Header iconACHV vs AXSM Comparison
Open Charts ACHV vs AXSMBanner chart's image
Achieve Life Sciences
Price$2.42
Change-$0.13 (-5.10%)
Volume$235.22K
Capitalization83.94M
Axsome Therapeutics
Price$107.89
Change-$1.86 (-1.69%)
Volume$754.31K
Capitalization5.26B
ACHV vs AXSM Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. AXSM commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and AXSM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ACHV: $2.42 vs. AXSM: $107.89)
Brand notoriety: ACHV and AXSM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 125% vs. AXSM: 85%
Market capitalization -- ACHV: $83.94M vs. AXSM: $5.26B
ACHV [@Biotechnology] is valued at $83.94M. AXSM’s [@Biotechnology] market capitalization is $5.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileAXSM’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • AXSM’s FA Score: 0 green, 5 red.
According to our system of comparison, AXSM is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 3 TA indicator(s) are bullish while AXSM’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 3 bullish, 4 bearish.
  • AXSM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than AXSM.

Price Growth

ACHV (@Biotechnology) experienced а -16.55% price change this week, while AXSM (@Biotechnology) price change was -11.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

ACHV is expected to report earnings on May 08, 2025.

AXSM is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXSM($5.26B) has a higher market cap than ACHV($83.9M). AXSM YTD gains are higher at: 27.514 vs. ACHV (-31.250). ACHV has higher annual earnings (EBITDA): -37.42M vs. AXSM (-272.6M). AXSM has more cash in the bank: 315M vs. ACHV (34.3M). ACHV has less debt than AXSM: ACHV (9.96M) vs AXSM (193M). AXSM has higher revenues than ACHV: AXSM (386M) vs ACHV (0).
ACHVAXSMACHV / AXSM
Capitalization83.9M5.26B2%
EBITDA-37.42M-272.6M14%
Gain YTD-31.25027.514-114%
P/E RatioN/AN/A-
Revenue0386M-
Total Cash34.3M315M11%
Total Debt9.96M193M5%
FUNDAMENTALS RATINGS
ACHV vs AXSM: Fundamental Ratings
ACHV
AXSM
OUTLOOK RATING
1..100
7760
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8942
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (63) in the Biotechnology industry is in the same range as AXSM (93) in the Pharmaceuticals Other industry. This means that ACHV’s stock grew similarly to AXSM’s over the last 12 months.

AXSM's Profit vs Risk Rating (64) in the Pharmaceuticals Other industry is somewhat better than the same rating for ACHV (100) in the Biotechnology industry. This means that AXSM’s stock grew somewhat faster than ACHV’s over the last 12 months.

AXSM's SMR Rating (100) in the Pharmaceuticals Other industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AXSM’s stock grew similarly to ACHV’s over the last 12 months.

AXSM's Price Growth Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for ACHV (89) in the Biotechnology industry. This means that AXSM’s stock grew somewhat faster than ACHV’s over the last 12 months.

AXSM's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AXSM’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVAXSM
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
75%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHGCY22.360.27
+1.22%
Chugai Pharmaceutical Co., Ltd.
GCEI0.08N/A
N/A
Global Clean Energy, Inc.
DNPLY6.89-0.07
-1.08%
Dai Nippon Printing Co. Ltd.
IPOOF1.11-0.02
-2.03%
InPlay Oil Corp.
KUBTY56.89-4.02
-6.61%
Kubota Corp.

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with AXSM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then AXSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-5.10%
AXSM - ACHV
36%
Loosely correlated
-1.69%
PLRX - ACHV
36%
Loosely correlated
-7.09%
PDSB - ACHV
34%
Loosely correlated
-9.09%
ATOS - ACHV
33%
Loosely correlated
-6.56%
ABOS - ACHV
32%
Poorly correlated
-8.52%
More

AXSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with VANI. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
-1.69%
VANI - AXSM
36%
Loosely correlated
-1.98%
PLRX - AXSM
35%
Loosely correlated
-7.09%
SWTX - AXSM
34%
Loosely correlated
-7.42%
CRNX - AXSM
34%
Loosely correlated
-8.03%
ACHV - AXSM
34%
Loosely correlated
-5.10%
More